×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 6 Track 2: Future of the Clinical Study Report
Session Chair(s)
Andrea Tuttle Meyers
Senior Vice President, Clinical Operations
Syneos Health, United States
The goal of this session is to discuss the evolution and future of the clinical study report (CSR). Medical Writing (MW) is one of the few functional areas in a clinical trial driven by people, not technology; however, there are companies piloting a CSR-less submissions. In this session, we have invited the company leading this effort to have a conversation on the future of the clinical study report and what role MW will play in the future regarding clinical study report production.
Learning Objective : At the conclusion of this session, participants should be able to:
- Assess a study and evaluate the feasibility of the clinical study report
- Evaluate the role of the medical writer as it applies to the clinical study report
- Describe how artificial intelligence may be applied to medical writing in the future
Speaker(s)
Speaker
Matt Becker
SAS Institute Inc., United States
Life Science Strategic Advisor